PLAY PODCASTS
The IMID Forum

The IMID Forum

431 episodes — Page 8 of 9

Rheumatology Author Prof Kevin Winthrop: Zoster

Prof Kevin Winthrop from Oregon Health & Science University. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition Prof Kevin Winthrop discusses the long-term effectiveness of the live zoster vaccine.

Apr 28, 202013 min

Rheumatology Registries for COVID-19

The global effort improving patient outcomes amid COVID-19. Past President of EULAR Prof Johannes Bijlsma discusses global rheumatology registries for COVID-19 with EULAR registry group member Prof Kimme Hyrich.

Apr 24, 202022 min

COVID-19: Considerations for Rheumatologists

COVID-19 guidance for rheumatologists. Prof Peter Nash discusses the challenges COVID-19 poses with infections specialist Prof Kevin Winthrop.

Apr 22, 202031 min

Perspectives in Inflammation – Prof Pierre Miossec

First to identify destructive properties of IL-17 and received the prestigious Carol Nachman prize in 2010 for his contribution. In this podcast, Prof Pierre Miossec discusses the pathophysiology of RA alongside Prof Tsutomu Takeuchi from Keio University. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Apr 9, 20208 min

Rheumatology Author Interview: Bone Homeostasis

Timo Gaber and Paula Hoff from Charité Berlin. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, the impact of tofacitinib on the bone healing process is discussed.

Apr 2, 202019 min

Rheumatology Author Prof Georg Schett: Osteoblasts

Prof Schett from University of Erlangen-Nuremberg. Join Prof Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Prof Schett discusses how JAK inhibitors can increase bone formation by stimulating osteoblasts.

Mar 27, 202023 min

Discussing Rheumatology: JAKi and Bone Biology

Prof Iain McInnes discusses bone homeostasis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed in this podcast is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Mar 23, 20207 min

Perspectives in Inflammation - Prof Iain McInnes

Muirhead Professor of Medicine, President of EULAR, and Sir James Black Prize Medal winner. In this podcast, Prof Iain McInnes discusses the inception of JAK inhibitors during his time at the National Institutes of Health with Prof Peter Nash from the University of Queensland. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Mar 11, 202012 min

Rheumatology Author Dr Orsolini: Osteoimmunology

Dr Giovanni Orsolini from the University of Verona. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Giovanni Orsolini discusses the potential of JAK inhibitors to halt bone erosion, independent of their effects on inflammation.

Feb 26, 202020 min

Discussing Rheumatology: JAK Selectivity

Prof Iain McInnes discusses JAK selectivity. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Feb 21, 202011 min

Perspectives in Inflammation - Prof Anca Catrina

Head of the Division of Rheumatology at Karolinska Institute and a co-author of more than 100 articles in peer review journals. In this podcast, Prof Anca Catrina discusses the role of antibodies in the pathogenesis of RA with Prof Johannes Bijlsma from University Medical Centre, Utrecht. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Feb 7, 202013 min

Rheumatology Author Prof Vibeke Strand: PROs

Prof Vibeke Strand from Stanford University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Vibeke Strand discusses improvements in patient-reported outcomes with upadacitinib.

Jan 29, 202032 min

Discussing Rheumatology: Tofacitinib Improves PROs

Iain McInnes discusses patient-reported outcomes. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.

Jan 22, 20209 min

Perspectives In Inflammation - Prof Kevin Winthrop

Member of the US Centers for Disease Control and a co-author of more than 100 publications. In this podcast, Prof Kevin Winthrop discusses the impact concomitant treatments have on HZ risk with Professor Maurizio Cutolo from the University of Genova. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.

Jan 8, 202015 min

Highlights of 2019

Professor McInnes presents the most notable papers of 2019. You can find detailed summaries of the papers highlighted on http://www.cytokinesignalling.com/en/publications/review-article/511/

Dec 23, 201911 min

December 2019 Monthly Podcast

Professor McInnes presents the monthly podcast reviewing a paper by Professor Ying‐Chou Chen and another paper by Professor Genovese.

Dec 23, 20199 min

November 2019 Monthly Podcast

Professor McInnes presents the monthly podcast reviewing a paper by Dr Katie Bechman and another paper by Professor Lee YH.

Nov 28, 20198 min

Congress Author Podcast - ACR 2019 Filgotinib

In this edition of Congress Author Podcasts, recorded at ACR 2019, the latest data from the FINCH studies are presented by Professors Taylor, Westhovens and Winthrop, in addition to filgotinib safety data from a phase 2 Psoriatic Arthritis trial, presented by Professor Coates.

Nov 22, 201924 min

Congress Author Podcast - ACR 2019 Tofacitinib and Baricitinib

In this edition, recorded at ACR 2019, real-world tofacitinib safety data is presented by Professor Kremer and the impact of baricitinib and tofacitinib on pain is analysed by Professors Taylor and Dougados

Nov 22, 201912 min

Congress Author Podcast - ACR 2019 Upadacitinib

In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.

Nov 22, 201926 min

ACR 2019 - Day 4 Highlights

Professor Calabrese introduces highlights from Day 4 of ACR 2019

Nov 19, 20195 min

ACR 2019 - Day 3 Highlights

Professor Calabrese introduces highlights from Day 3 of ACR 2019

Nov 19, 20192 min

ACR 2019 - Day 2 Highlights

Professor Calabrese presents highlights from Day 2 of ACR 2019

Nov 19, 201912 min

ACR 2019 - Day 1 Highlights

Professor Kevin Winthrop introduces the key abstracts from Day 1 at ACR 2019

Nov 19, 201911 min

October 2019 Monthly Podcast

Professor McInnes presents the monthly podcast reviewing a paper by Professor Bruno Fautrel and another paper by Professor Christina Charles-Schoeman.

Oct 31, 20198 min

September 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing a paper he authored along with colleagues and another paper by Dr Mori Shunsuke.

Sep 26, 201910 min

Author Interview - Professor Fleischmann

Professor Nash Interviews Professor Fleischmann from the University of Texas Southwester Medical Center, about his two recently published papers on upadacitinib.

Sep 19, 201935 min

Author Interview - Professor Calabrese

Professor Nash Interviews Professor Leonard Calabrese from the RJ Fasenmyer Center for clinical Immunology, about his paper examining the live zoster vaccine in patients treated with tofacitinib monotherapy, tofacitinib with MTX and adalimumab with MTX.

Sep 9, 201919 min

Perspectives in Inflammation - Professors Iain McInnes and Johannes Bijlsma

Professor Iain McInnes joined by Professor Johannes Bijlsma, discusses the changes required to educate the next generation of rheumatologists, highlighting the benefits of online educational courses and the importance of quality amid a plethora of information.

Sep 9, 201915 min

August 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Professor Fleischmann and Professor Takeuchi.

Aug 27, 20197 min

Author Interview - Dr Roland Grenningloh

Professor Nash interviews Dr Roland Grenningloh from the EMD Serono Research and Development Institute, about his paper describing the PK modelling of the novel Bruton’s tyrosine kinase (BTK) inhibitor, evobrutinib, in disease models for RA and lupus.

Aug 14, 201920 min

July 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Professor Tanaka and Professor Calabrese.

Jul 29, 201910 min

June 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Professor Josef Smolen and Professor Wenhui Xie, respectively.

Jun 27, 201910 min

Author Interview - Professor Winthrop

Professor Nash interviews Professor Kevin Winthrop from Oregon Health Sciences University, Portland or USA, about his paper investigating pneumococcal and tetanus vaccine responses in patients with RA receiving baricitinib treatment.

May 30, 201923 min

May 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Professor Winthrop K and Professor Wollenhaupt J, respectively

May 23, 201911 min

Author Interview - Professor Combe

Professor Nash interviews Professor Bernard Combe from the University of Montpellier, France, about a letter investigating the safety of baricitinib treatment in patients with select comorbidities.

May 10, 201914 min

April 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Professor Combe B and Dr. Zhang Z, respectively

Apr 25, 201910 min

Author Interview - Professor Takeuchi

Professor Nash interviews Professor Tsutomu Takeuchi from Keio University School of Medicine, about the paper looking at safety profile of baricitinib in Japanese patients.

Apr 23, 201913 min

Speciality Podcast - Pain Podcast

Professor McInnes reviews key abstract from ACR 2018, relating to pain and JAK inhibitors.

Apr 10, 201912 min

March 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Dr. Chengfeng Qiu and Dr. Camean-Castillo, respectively

Mar 22, 201911 min

Author Interview - Professor Taylor

Professor Nash interviews Professor Peter Taylor from the University of Oxford, about his paper looking at effects of baricitinib on lymphocyte subsets in rheumatoid arthritis

Mar 13, 201917 min

February 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Prof Peter Taylor and van der Heijde, respectively

Mar 4, 201911 min

January 2019 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Prof Tanaka and Kivitz, respectively

Jan 28, 20199 min

December 2018 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Head of Clinical Pharmacology at Galapagos, Florence Namour, and Prof van Vollenhoven

Jan 11, 20198 min

Author Interview - Florence Namour

Professor Nash interviews Florence Namour from Galapagos about her recent paper: Influence of Age and Renal Impairment on the Steady State Pharmacokinetics of Filgotinib, a Selective JAK1 Inhibitor

Jan 7, 201914 min

November 2018 Monthly Podcast

Prof McInnes presents the monthly podcast reviewing two papers from Prof van Vollenhoven and Prof Curtis

Dec 4, 20187 min

Author Interview - Professor Curtis

Professor Nash interviews Professor Curtis about his recent paper: Herpes zoster in Tofacitinib: Risk is Further Increased with Glucocorticoids but not Methotrexate

Dec 4, 201819 min

ACR Author Interviews

Dr Tracy Lovatt, Scientific Director for CESAS Medical, interviews ACR poster authors; Dr Litman, Dr Dominguez-Casas, Professor Fleischmann, Dr Mirza, Professor Taylor, Professor Kivitz and Dr Kunder.

Nov 16, 201822 min

October 2018 Monthly Review

Prof McInnes presents the monthly podcast reviewing two papers from Prof Takeuchi and Prof Smolen

Oct 29, 20186 min

September 2018 Monthly Review

Prof McInnes presents the monthly podcast reviewing two papers from Prof Kremer and Prof Taylor

Oct 9, 201812 min